Brain Immune Cells Spread Aging Signals Through Newly Discovered Cellular Packages

Cognitive decline with aging is closely tied to the accumulation of senescent cells in the brain, but the mechanisms by which senescence propagates between different brain immune cell types have remained poorly understood. This study, published in Nature Aging, uncovers a striking new intercellular communication pathway that accelerates brain aging.

The researchers focused on border-associated macrophages (BAMs), a distinct population of brain-resident immune cells found in the meninges, choroid plexus, and perivascular spaces. They found that BAMs acquire senescence-associated features during early brain aging, likely triggered by prolonged exposure to amyloid beta — the peptide central to Alzheimer's disease pathology. These senescent-like BAMs are not merely passive bystanders; they actively amplify aging throughout the brain.

The key mechanism involves migrasomes — organelles that bud off from cells during migration and were only recently characterized as intercellular communicators. Senescent-like BAMs produce significantly more migrasomes than healthy cells, and these structures carry potent senescence-associated cargo, notably the apoptosis inhibitor of macrophage (AIM) protein. Microglia, the brain's primary immune sentinels, are the principal recipients of these migrasomes. Upon uptake, AIM activates the CD16 receptor in microglia, suppressing their apoptosis and inducing a senescent state — essentially converting healthy microglia into new senescence hubs.

Critically, blocking migrasome production in senescent-like BAMs using Tspan4-targeting siRNA delivered via liposomes meaningfully improved cognitive performance in aged mice, demonstrating therapeutic proof-of-concept.

Caveats include reliance on mouse models, which may not fully replicate human brain aging dynamics. The study also used abstract-level data only, limiting assessment of full mechanistic detail and off-target effects of the siRNA intervention.